1. Home
  2. ANNX vs MEG Comparison

ANNX vs MEG Comparison

Compare ANNX & MEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.64

Market Cap

918.2M

Sector

Health Care

ML Signal

HOLD

Logo Montrose Environmental Group Inc.

MEG

Montrose Environmental Group Inc.

HOLD

Current Price

$23.47

Market Cap

846.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANNX
MEG
Founded
2011
2012
Country
United States
United States
Employees
N/A
3500
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
918.2M
846.0M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
ANNX
MEG
Price
$5.64
$23.47
Analyst Decision
Strong Buy
Buy
Analyst Count
6
4
Target Price
$16.50
$33.50
AVG Volume (30 Days)
2.3M
328.0K
Earning Date
03-02-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$826,323,000.00
Revenue This Year
N/A
$19.70
Revenue Next Year
N/A
$2.82
P/E Ratio
N/A
N/A
Revenue Growth
N/A
22.77
52 Week Low
$1.29
$10.51
52 Week High
$7.18
$32.00

Technical Indicators

Market Signals
Indicator
ANNX
MEG
Relative Strength Index (RSI) 45.15 47.79
Support Level $6.10 $21.92
Resistance Level $6.59 $24.05
Average True Range (ATR) 0.43 0.99
MACD -0.14 0.15
Stochastic Oscillator 10.57 81.00

Price Performance

Historical Comparison
ANNX
MEG

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, remove contaminant or create biogas. United States Contributes the majority of geographic revenue.

Share on Social Networks: